Geographic · Total revenues

United States — Total revenues

Vertex Pharmaceuticals United States — Total revenues increased by 6.8% to $1.78B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.8%, from $1.66B to $1.78B. Over 2 years (FY 2022 to FY 2024), United States — Total revenues shows an upward trend with a 8.3% CAGR.

Analysis

StatementSegment
First reportedQ1 2016
Last reportedQ1 2026May 5, 2026
Rolls up toTotal Revenue
Metric ID: vrtx_segment_united_states_total_revenues

Historical Data

16 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q1 '26
Value$1.26B$1.38B$1.37B$1.42B$1.46B$1.46B$1.40B$1.51B$1.55B$1.57B$1.52B$1.61B$1.71B$1.84B$1.66B$1.78B
QoQ Change—+10.0%-1.1%+3.4%+2.9%+0.3%-3.9%+7.4%+3.1%+1.3%-3.5%+6.2%+6.1%+7.2%-9.5%+6.8%
YoY Change———+12.6%+5.3%—+2.6%+6.6%+6.8%+7.8%+8.3%+7.1%+10.2%+16.7%+9.4%+6.8%
Range$1.26B – $1.84B
CAGR+9.7%
Avg YoY Growth+8.3%
Median YoY Growth+7.4%

Frequently Asked Questions

What is Vertex Pharmaceuticals's united states — total revenues?
Vertex Pharmaceuticals (VRTX) reported united states — total revenues of $1.78B in Q1 2026.
How has Vertex Pharmaceuticals's united states — total revenues changed year-over-year?
Vertex Pharmaceuticals's united states — total revenues increased by 6.8% year-over-year, from $1.66B to $1.78B.
What is the long-term trend for Vertex Pharmaceuticals's united states — total revenues?
Over 2 years (2022 to 2024), Vertex Pharmaceuticals's united states — total revenues has grown at a 8.3% compound annual growth rate (CAGR), from $5.70B to $6.68B.